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Background: Data on knowledge, attitudes, behaviour and practices (KABP) of persons with recent HIV infection
compared to controls with negative HIV test result provide information on current risk patterns and can help to
re-focus HIV prevention strategies.
Methods: From March 2008 through May 2010, persons newly diagnosed with HIV (cases) and HIV-negative
controls were recruited by physicians in Germany. To distinguish recent (< 5 months) from longstanding
(> 5 months) infection, dried blood spots from people newly diagnosed with HIV were tested with the BED
IgG-capture ELISA. Cases and controls completed a KABP-questionnaire. We compared cases with recent infection
and controls among men having sex with men (MSM) regarding reported risk behaviour in the previous 6 months.
To detect differences, unadjusted Odds Ratios (OR) were calculated and multivariate analysis was performed.
Results: Cases and controls did not differ in terms of knowledge on transmission risks, HIV testing frequency,
partnership status, or regarding the frequency of any unprotected sex with partners known to be HIV-positive or
assumed to be HIV-negative. Cases more often reported a shorter duration of partnership (< 6 months) with a
primary partner than controls (OR = 3.9; p = 0.003) and indicated lower rates of condom use outside of primary
relationships, with acquaintances (OR = 2.5; p = 0.01), and with persons met online (OR = 4.5; p = 0.04). Unprotected
sex with persons of unknown HIV-serostatus was more often indicated by cases than controls (OR = 3.0; p = 0.003).
Having a conversation about HIV serostatus before having sex was associated with a lower risk of infection
(OR = 0.2; p = 0.01). In multivariate analysis “being always safe” (always using a condom when having sex in different
situations outside of a relationship) and talking about serostatus before sex (OR = 0.23; p = 0.004; OR = 0.14; p = 0.014)
were negatively associated with HIV- infection.
Conclusions: There were no significant differences regarding knowledge about HIV-transmission risks among cases
and controls. Differences in risk behaviour were observed regarding unprotected sex with partners of unknown
HIV-serostatus and duration of primary partnership at the time of diagnosis, suggesting some HIV-transmissions
occurring in newly formed partnerships. The practice of discussing serostatus with prospective sex partners
before engaging in sex seems to be protective for HIV-transmission.
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The HIV epidemic in Germany is a concentrated epidemic
with sub-populations, especially men having sex with men
(MSM), being disproportionately affected by HIV [1]. Re-
cent estimates indicate that the majority (51,000) of the
78,000 persons living with HIV in Germany are MSM,
followed by 17,000 persons with heterosexual transmis-
sion and approximately 8,500 people who inject drugs.
The estimated HIV incidence in MSM steadily declined
after the beginning of the epidemic in the early 1980’s.
However, since 2001 HIV incidence among MSM has in-
creased again [2] and this group still remains one of the
key populations for HIV infection, transmission and pre-
vention in Germany.
Reasons for the increasing HIV incidence in MSM
have been attributed to changes in risk behaviour, such
as increasing number of sex partners, higher frequency
of unprotected anal sex [2,3] and substance use [4,5]. An
increase of reported syphilis cases and other bacterial
sexually transmitted infections may also contribute to
increasing HIV incidence by increasing the transmission
probability for HIV [2,6-10]. In addition, research has
shown that MSM have implemented various risk reduction
and management strategies, such as choosing a partner
based on disclosed or assumed serostatus (serosorting) or
selecting sexual activities based on HIV-status (seroposi-
tioning) [11-14]. In gay couples practices like “negotiated
safety” [15], intending to reduce risks of HIV-acquisition
outside of steady relationships while allowing condom-less
sex between HIV seroconcordant steady partners are
commonly used to reduce risk of HIV-acquisition and
transmission within relationships [16]. Whether or not
these risk reduction strategies are effective depends on
multiple factors such as honest disclosure of serostatus,
regular testing for HIV (after potential risks), occurrence
of sexually transmitted infections and consistency of be-
havior [12,13,17].
All these factors show the importance of research on
preventive and risk behaviours among MSM to under-
stand the specific prevention needs of this group. Studies
on knowledge, attitudes, behaviour and practice (KABP)
are needed [18-21] to provide an understanding of risk
behaviour and help to identify possible protective factors
that can be utilized for prevention messages and inter-
vention planning [22]. Ideally KABP-studies are com-
bined with biological data to determine serostatus of
respondents and compare risk and preventive behaviour
of individuals with different serostatus [22-24].
UNAIDS and WHO developed the concept of second
generation surveillance, combining both the monitoring
of biological (new cases of HIV/AIDS) and behavioral
indicators (e.g., sexual behaviour, use of protection). This
type of surveillance is recommended in particular for
populations at high risk to acquire HIV infection, suchas MSM [22,25]. Following this concept, HIV surveil-
lance in Germany is based on three pillars: Mandatory
reporting of new HIV diagnoses (since 1988), long-term
cohort studies focusing on treatment and long-term ef-
fects in people living with HIV, as well as studies among
sub-populations most at risk for HIV infection. Monitor-
ing of recent HIV infections was first introduced into the
German HIV surveillance system in 2005 for assessment
of current dynamics of the HIV epidemic in Germany and
for identification of populations at risk for HIV-infection.
To determine recency of infection (< 5 months) the BED
IgG-capture-ELISA is used [26,27].
Combining KABP and biological data can be helpful to
get information about risk and protective behaviour in
individuals with different serostatus. By adding testing
for recency of infection in newly diagnosed cases, it be-
comes possible to restrict comparative analysis to indi-
viduals with recent HIV infection who have been at risk
within the previous five months. The objective of this
study was the identification of behavioural factors pro-
tecting MSM from HIV acquisition.
Methods
Study design and data collection
Participant recruitment took place from March 2008
through May 2010. 72 study sites offering HIV testing in
35 cities from different regions in Germany (Figure 1),
accounting for approximately 70% of all reported HIV
diagnoses from 2000–2006 were included. Study sites in-
cluded private practices (74%), outpatient clinics (13%),
local health authorities (11%), and other agencies (0.2%).
Participants were recruited through convenience sam-
pling, and participation was offered right before or some-
times after receiving an HIV test result. Eligible persons
were informed about the study by test counsellors or phy-
sicians, and written informed consent was obtained from
each participant.
Although we tried to recruit persons from all sub-
groups with higher risk of HIV infection (MSM, migrants,
intravenous drug users, persons with heterosexual trans-
mission), sub-samples other than MSM were too small for
analysis.
Cases were defined as men who accessed HIV testing
services, reported having sex with other men, and being
diagnosed with HIV. Controls were male individuals who
accessed HIV testing services, reported having sex with
other men, and having received a negative test result.
Inclusion criteria for cases and controls were i. age 18
or older. ii. signed informed consent. iii. having received
an HIV test result. For cases inclusion criteria was ex-
tended to: iv. confirmed HIV-diagnosis within the last
12 weeks (ELISA reactive and Immunoblot positive). Cases
and controls were matched for age group, and WHO-
region of birth/origin.
Figure 1 Cities with recruitment sites (map of Germany with
federal states). We have the copyright to this file.
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naire for cases and controls (“physicians questionnaire”),
covering: i. demographic information, ii. transmission
risk, iii. last negative test result, iv. probable source of
transmission, v. symptoms, vi. in cases information on
anti-retroviral therapy.
When accessing pre-test counselling and before receiv-
ing the HIV-test result, cases and controls were asked to
complete a standardized questionnaire (“patients’ ques-
tionnaire”), containing questions on KABP and other
information. The following sections were covered in the
patients’ questionnaire:
 Personal and demographic information (e.g., level of
education, sexual orientation, partnership status,
country of origin)
 HIV testing history (month and year of last test)
 Knowledge about HIV (HIV epidemiology in
Germany, transmission risk (“How do you assess the
transmission risk in the respective situation?”)
Response categories: High risk, intermediate risk,
low risk, no risk, don’t know)
 Effects of anti-retroviral therapy (ART) on disease
progression and infectiousness Sources of information about HIV (“Where did you
get information about HIV?”)
 Condom use with different partners during the last
six months (at the beginning of a new relationship,
with primary partner, outside of primary
relationship, sex with an acquaintance, sex with a
person met online, anonymous sex, sex with an
HIV-positive person). Response categories: always,
mostly, rarely, never)
 Reasons for not using condoms at last unprotected
intercourse (multiple response options e.g., ”I
assumed that my partner was negative.” “We had a
face-to-face conversation about serostatus before
sex.”)
 Risk behaviour
 Sex during the last 6 months
 Number of sex partners within last 6 months
 Unsafe sex during the last 6 months (vaginal/
anal/oral) (with persons you assumed were HIV-
negative, with persons with unknown serostatus,
with persons with HIV)
 History of sexually transmitted infections (STI)
(syphilis, gonorrhoea, chlamydia, herpes, venereal
warts)
Physicians’ and patients’ questionnaire, as well as the
informed consent form, were pre-tested in a pilot study
in Berlin in 2007 [26,27] and adapted afterwards. The
patient questionnaire was available in German, English
and French. After the first year of data collection, some
items were modified: The response category “with person
met online” was introduced into the questions on condom
use with different partners, and the response option “I was
certain that sex partner was HIV negative, because we
talked about our serostatus” was added as possible cat-
egory to the questions on reasons for not using a condom
at last sex. The latter was added, because a high number
of study participants listed this as a reason for not using
condoms in the “other reasons” option.
A unique identifier was assigned to all patients’ question-
naires and it was impossible to trace patients’ identities.
Patients participated voluntarily and did not receive com-
pensation. Study sites received an allowance of €30 for
every case and €20 for a matched control. Questionnaires
were sent to Robert Koch Institute (RKI) and entered into
an Access-database. Ethics approval was received from the
ethics board at the Charité Berlin (medical university and
clinic).
Laboratory tests
Capillary blood was obtained from cases by finger prick
and then applied onto filters (Whatman #903). Filters
were dried for at least three hours and sent to the HIV-
laboratory at RKI via regular mail. The BED IgG-capture
Table 1 Study population: demographic characteristics of
cases and controls




> 45 11% 14%
Level of education
Secondary school certificate
or completed 8/9th grade
17% 15%
Completed 10th grade 30% 27%
High school graduate 27% 25%
University degree 23% 33%
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Oswego, USA) was performed from dried blood spots
(DBS) to distinguish recent (acquired within the last
5 months) from longstanding (> 5 months) infections.
The evaluation of the test and validation for its use
from DBS is described elsewhere [28,29]. Sensitivity and
specificity of BED-CEIA were acceptable (82% and 85%
respectively) and comparable to values published earlier
[30]. We increased specificity and positive predictive value
by using a lower cut-off for the normalized optical
density (from 0.80 to 0.65) as described previously [27]
and increased specificity and positive predictive values to
97.6% and 93.6% respectively. Consequently, samples clas-
sified as “recent” were very likely to truly be recently
acquired infections. Results of BED-CEIA were linked
with responses from the physicians’ and the patients’
questionnaires.
Data analysis
Data was analyzed using SPSS 20.0. We compared re-
ported knowledge about HIV, partnership status, duration
of partnership, condom use and sexual risk behaviour be-
tween recently infected MSM and HIV-negative controls.
We created the variable “always safe” which was defined
as always using a condom when having sex outside of a
relationship, with an acquaintance, with a person met on-
line, a stranger, or with an HIV-positive person or not en-
gaging in these situations. To detect differences between
cases and controls chi-square test and unadjusted Odds
Ratios (OR) were calculated. A multivariate analysis was
subsequently conducted including factors found to differ
between cases and controls using a significance level of
p ≤ 0.05 of all results in bivariate analyses.
Results
Study population
The study population consisted of 105 cases with recent
HIV-infection and 105 matched controls.
Mean age of cases and controls was 34 years and the
majority of the study population was between 30–44
years of age (52%) or younger (35%) (Table 1). Most
common country of origin was Germany (90%), followed
by Western European (cases 7%; controls 5%), Central
European (5%) or Latin American countries (2%). Level
of education was high, with approximately 50% of study
population having a high school or university degree
(Table 1). There were no significant differences in level
of education between cases and controls. 3% of cases
and 0% of controls reported intravenous drug use in the
previous 6 months.
Knowledge on HIV and HIV testing
The level of knowledge about HIV as well as on transmis-
sion risks was high in the study sample with no differencebetween cases and controls. The majority of cases (97%)
and controls (94%) recognized unprotected receptive anal
sex with ejaculation as high risk for HIV transmission.
Both groups were likely to overestimate transmission risk;
73% of cases and 57% of controls considered oral sex with
ejaculation as high-risk behaviour (Table 2).
Only 8% of cases and controls agreed with the state-
ment that an HIV positive person with undetectable viral
load cannot transmit HIV sexually, whereas the majority
(66% cases and 69% controls) did not concur or did not
know (26% vs. 24%). The proportion of MSM testing for
HIV at least twice within the last twelve months was simi-
lar in cases and controls (85% vs. 81%).
Relationship status and duration of partnership
Most participants were single (44% vs. 46%), or currently
living in an allegedly monogamous same-sex relation-
ship (37% vs. 32%). Controls were more likely to live in
a non-monogamous (sex with other people accepted)
same-sex relationship (2% vs. 7%) or a steady heterosexual
partnership (0% vs. 5%). 50% of cases in comparison
to 20% of controls had been in a relationship with a pri-
mary partner for less than six months (OR = 3.9; p = 0.03),
whereas controls more often reported relationships lasting
more than 12 months (OR = 0.25; p = 0.001) (Table 3).
Number of sex partners
94% of cases and 93% of controls indicated that they had
sex within the last 6 months. Information on number of
male sex partners in that time period was available for
76 cases and 78 controls. There was a significant differ-
ence in number of sex partners between cases (mean =
11.8; median = 5) and controls (mean = 6.6; median = 4)
(p = 0.03 (t-test)). 18% of cases and controls reported be-
ing monogamous over the last six months, whereas 12%
of cases and 4% of controls reported more than 20 part-
ners) (p = 0.06, 95%). Most cases (70%) and controls
(78%) had between 2 and 20 sex partners (Table 3).
Table 2 Transmission risk perceptions in different situations (cases and controls)
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23% of cases and 22% of controls reported an STI within
the last 6 months. STIs that occurred among the study
population were syphilis (11 cases/5 controls), gonorrhea
(4 cases/10 controls), venereal warts (5 cases/6 controls),
herpes (4 cases/2 controls), chlamydia infection (3 cases/
1 control) and three other STIs (1 case/2 controls).
18% of cases and 11% of controls had engaged in UAI
with an HIV positive person, a difference which was not
statistically significant. Cases more often had UAI with
persons of unknown serostatus than controls (62% vs.49%; OR = 3.1; p = 0.001). With regards to sexual prac-
tices, there was no difference in frequency of insertive
UAI between the two groups. However, cases more often
reported receptive UAI than controls (43% vs. 19%; RR =
3.3; p = 0.005) (Table 4).
Reasons for not using condoms during last unprotected
(vaginal/anal) sex
85% of cases and 81% of controls marked at least one rea-
son for not using condoms during last unprotected inter-
course. Overall the most common reasons for not using
Table 3 Relationship status, duration of partnership and number of partners
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http://www.biomedcentral.com/1471-2458/14/453condoms were “thought there was no risk” (n = 55) and
“hoped that nothing would happen” (n = 49) (Table 4).
Cases more often assumed that the partner was HIV nega-
tive (OR = 3.6; p = 0.003). Being certain or convinced that
the HIV serostatus of the partner was associated with
lower odds of acquiring HIV (OR = 0.3, p = 0.06). Having
a conversation about serostatus with a sex partner before
engaging in sex was significantly associated with a lower
odds of HIV infection (OR = 0.16; p = 0.001) (Table 5).
Condom use
We compared frequency of condom use in various situa-
tions. Fifty-six percent of cases and 66% of controls indi-
cated always using condoms in the beginning of a new
relationship, whereas 44% of cases and 34% of controls
stated using condoms inconsistently. This difference was
not statistically significant. There was also no difference
in condom use during relationships, with strangers or an
HIV positive partner (Table 3). Cases reported lower
rates of condom use outside of primary relationships
(42%/30%; OR = 2.3; p = 0.012), with acquaintances (62%
vs. 43%; OR = 2.2; p = 0.016), and with persons met on-
line (55%/22%, OR = 4.4; p = 0.005). Controls reported
more often than cases to have been “always safe” (29%
vs. 9%, OR = 4.6; p = < 0.000) (Table 4).Results from multivariate analysis
Variables included in multivariate analysis were age, dur-
ation of partnership, number of sex partners, UAI (re-
ceptive and insertive), unprotected sex with a person of
unknown serostatus, conversation about serostatus, and
being “always safe” (Table 6). We used two models, one
including the variable “conversation about serostatus” and
one without. Two factors were negatively associated with
the outcome variable (recent HIV infection): Being “al-
ways safe” (OR = 0.23; p = 0.004) and having had a conver-
sation about serostatus before sex (OR = 0.14; p = 0.014).
Discussion
The present study examines differences of risk and pre-
ventive behavior between MSM with recent HIV infec-
tion and MSM with a confirmed negative HIV status in
Germany. Cases and controls did not differ with regard
to knowledge about HIV, relationship status or the oc-
currence of STIs. However, we must emphasize that
screening for asymptomatic STI for MSM not diagnosed
with HIV is rare in Germany [31,32], implying that most
STI diagnosed in the study population were probably symp-
tomatic. Duration of primary partnership at the time of
diagnosis was shorter for cases compared to controls, sug-
gesting HIV transmission in newly formed partnerships.
Table 4 Condom use and partner characteristics
Unprotected anal intercourse
Cases Controls OR p-value CI





























































0.23 < 0.000 0.11–0.52
*Never, rarely or mostly used a condom.
**Person always used a condom when having sex outside of a relationship or did not have anal sex in the respective situation.
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a correlation between the number of sex partners and the
risk of HIV transmission. Cases reported less consistent
condom use outside of primary relationships, with acquain-
tances and persons met online. Explicitly addressing HIV
serostatus with sex partners before engaging in sexual activ-
ities seemed to protect from contracting HIV.
Knowledge on HIV transmission and testing was high
among both cases and controls with no difference betweenTable 5 Reasons for not using condoms at last unprotected s
Reasons for not using condoms Cases
(n = 90)
No condom available 14% (n = 1
Would have disturbed the mood 13% (n = 1
I thought there was no risk 38% (n = 3
I hoped that nothing would happen 32% (n = 2
Condom caused erection problems 11% (n = 1
Assumed partner was negative. 28% (n = 2
Convinced partner was negative** 10% (n = 9
Talked with partner about serostatus before having sex** 3% (n = 3)
**Smaller n due to modified version of questionnaire.the two groups. Most MSM in this study overestimated
potential risks. For example, the majority of participants
did not know that sex with an HIV-infected person re-
ceiving effective ART puts them at low risk for HIV
transmission. However, this statement by the Swiss
Federal Commission for Sexual Health had been pub-
lished in 2008 [33] shortly before this study was conducted
and, might have been discussed only among people living




3) 7% (n = 6) 2.1 0.1 0.79–5.88
2) 17% (n = 14) 0.8 0.5 0.56–2.99
4) 25% (n = 21) 1.8 0.7 0.95–3.49
8) 25% (n = 21) 1.4 0.4 0.28–1.44
0) 14% (n = 12) 0.75 0.5 0.54–3.27
5) 10% (n = 8) 3.6 0.003 1.54–8.33
) 20% (n = 17) 0.3 0.06 0.10–1.52
19% (n = 16) 0.2 0.001 0.04–0.52
Table 6 Results from multivariate analysis (final model)
Variable Odds ratio p-value CI
Age 0.98 0.539 0.96–1.07
Conversation about serostatus before sex 0.18 0.014 0.05–0.71
Unprotected sex with person with unknown serostatus 1.47 0.464 0.24–1.90
Insertive UAI with person with unknown serostatus 0.83 0.785 0.32–4.47
Receptive UAI with person with unknown serostatus 2.13 0.249 0.59–7.69
“Always safe”** 0.23 0.004 0.08–0.625
**Person always used a condom when having sex s outside of a relationship or did not have anal sex in the respective situation.
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population with a higher risk of HIV transmission, are
generally well informed about risks and facts on HIV. This
demonstrates once again that knowledge on HIV by itself
does not determine risk behaviour [19,34]. Other KABP-
studies among German MSM also indicate good overall
knowledge of HIV transmission risks; however the degree
of knowledge is influenced by level of education [35]
which was rather high in our study and might have intro-
duced selection bias.
Notably, 9% of MSM with recent HIV infections re-
ported being “always safe” within the last six months.
This is surprising, because these cases had acquired HIV
within the last five months and most have been exposed
to risk behaviour. One possible explanation for this dis-
crepancy is that participants do not remember or do not
want to report risk events. Also, three cases indicated
intravenous drug use during the last 6 months and
might have not had sexual risk. Furthermore, the specifi-
city of the BED-CEIA is not 100% and there might have
been some misclassifications.
Conversation about serostatus: “Serotalking”
The practice of serosorting, which is defined as having
sex without condoms exclusively or preferentially with
partners of concordant HIV status and of using condoms
with HIV-discordant or HIV status unknown partners,
has become increasingly common among MSM
[12,14,36,37]. Research has shown that this practice can
increase the risk of acquiring HIV and other STIs
[13,14,36,38,39], whereas others have found that this
practice might decrease risk of infection [11]. Whether
serosorting might or might not work as a risk manage-
ment strategy is influenced by various factors, such as
the prevalence of HIV in the population; the explicitness
of communication; the proportion of people living with
HIV who are aware of being infected; the incidence of
new HIV infection among people previously testing
negative for HIV and practicing HIV serosorting, and
their position in sexual networks; the willingness to dis-
close HIV infection to a potential sex partner; the con-
text of serostatus communication; and the proportion of
people living with HIV under effective ART [14,37].Our results suggest that the way serosorting is per-
formed might have an impact on HIV transmission risk.
One of the key findings was that having an explicit conver-
sation about HIV serostatus before sexual activity reduces
the risk of acquiring HIV. This might be attributable to the
mode of serostatus communication: namely a direct and
explicit conversation might be protective, whereas other
ways of serosorting, such as relying on online profiles, or
guessing/assuming HIV status based on appearance, might
be much less effective. This interpretation is supported by
the finding that “assuming my partner was HIV-negative”
was associated with an increased risk of being diag-
nosed with HIV in bivariate analysis. Direct commu-
nication compared to non-verbal perceptions reduces
the potential for misinterpretations such as “he must
be HIV-positive/HIV-negative because he doesn’t insist on
condom use”. MSM diagnosed with HIV rarely report
UAI with non-steady partners known to be serodiscor-
dant, but relatively frequently report UAI with HIV seros-
tatus unknown partners.
Further research should investigate the utilization of
serotalking by persons with different relationship status
and thus examine whether serotalking is more likely
used among MSM in steady relationships than by MSM
engaging in casual sex with non-primary partners. Ac-
cording to former research the duration of partnership
might have an impact on truthfully disclosing risk be-
haviour and serostatus [15]. Also, further research is
needed to determine what information and topics sero-
talking should entail to become an effective risk manage-
ment strategy.
Of course, a direct and explicit conversation about ser-
ostatus might not always be possible or feasible before
having sex, e.g., in anonymous sex venues, and conse-
quently “serotalking” cannot be promoted as the “one
and only” risk management strategy. In our study, sex
with acquaintances or with partners met online was ra-
ther common, and in these situations communication
about serostatus might be an appropriate risk reduction
strategy. Ideally, such communication should contain
not only, but also information on recency of test results
and number of potential HIV exposures since the last
test [40,41].
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There are some limitations to consider when interpret-
ing our results. Our study was conducted in 2008–2010,
an era when late antiretroviral treatment initiation was
still common in Germany (CD4 threshold for treatment
initiation was increased from 200 CD4 cells/μl to 350
CD4 cells/μl in a treatment guideline update in Septem-
ber 2008) [42]. Meanwhile, among MSM close to 90% of
men diagnosed with HIV are receiving ART. Most MSM
who could effectively transmit HIV today are likely to be
unaware of being infected [43]. Serostatus communica-
tion as a HIV risk management strategy might therefore
be less efficient today compared with the situation a few
years ago.
With our sampling strategy we only reached MSM
who accessed HIV testing services in the respective
study sites. Therefore, our study population might in-
clude a high number of persons who have a concrete
reason to get tested, namely a previous high risk situation.
Also, we did not reach MSM who do not access testing.
The KABP-questionnaire was not developed specifically
for MSM, but we initially tried to recruit participants from
all populations relevant for HIV-transmission in Germany.
Consequently, some of the questions might not reflect the
language or the specific situation of MSM (e.g., no ques-
tions on specific sex venues; substance use; in questions
on sex with persons with unknown and positive serosta-
tus, first response choice was vaginal sex). Because we
reached predominantly MSM with the study, we changed
some items of the questionnaire during the study period,
which might have created limitations to comparability.
Further, some of the questions had many response op-
tions, making the questionnaire more complicated and
potentially causing missing answers. We did not include
questions on UAI in new partnerships in order to under-
stand what happens in the early stages of a relationship.
We also did not add questions on substance use and alco-
hol consumption (except for intravenous drug use), even
though this might affect risk behaviour and condom
use. Lastly, the sample is rather small (105 cases and con-
trols) and with a bigger sample size we might have been
able to detect and identify other relevant risk or pro-
tective factors.
Conclusion
We observed differences in risk behaviour between MSM
with recent HIV-infection and HIV-negative controls re-
garding unprotected sex with partners of unknown HIV-
serostatus, and duration of primary partnership at the
time of diagnosis, suggesting some HIV-transmissions oc-
curring in newly formed partnerships. Having a conversa-
tion about serostatus with prospective sex partners before
engaging in sex was associated with lower odds of HIV-
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